Overview

Investigation of Drug-drug Interaction of Dabigatran and Ticagrelor

Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
To investigate the pharmacokinetic and pharmacodynamic interaction of dabigatran and ticagrelor under steady state conditions; to investigate the effect of staggered administration of ticagrelor loading dose on dabigatran exposure (in Part II)
Phase:
Phase 1
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Dabigatran
Ticagrelor